Raloxifene clinical trials
Also written Evista and LY139481.
How each study uses raloxifene is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the raloxifene studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 9 Dec 1997 · EVISTA · NDA 020815 (FDA, Drugs@FDA)
- European Union
- 5 Aug 1998 · Evista · EMEA/H/C/000184 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
46 studies that test it; most in 1998 (4)
| Year | Studies |
|---|---|
| 1994 | 1 |
| 1998 | 4 |
| 1999 | 2 |
| 2000 | 2 |
| 2001 | 4 |
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 2 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 12 · Other 35
Eli Lilly and Company (9) · The Alfred (3) · Fundació Sant Joan de Déu (2) · Mayo Clinic (2) · University of Wisconsin, Madison (2) · Massachusetts General Hospital (1) · Hospital de Clinicas de Porto Alegre (1) · Yonsei University (1)
Often tested with
Tested in the same studies.
Teriparatide (5) · Alendronate (2) · Cholecalciferol (2) · Bicalutamide (2) · Multimodality Therapy (1) · Exemestane (1) · Tamoxifen (1) · Goserelin (1)
Related medicines
As reviewed, each with the page that says it.
- One of Estrogen Antagonists source
- One of SERMs source
Studies
Open first, then newest update. How each study uses raloxifene is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 47
- Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the BrainRecruitingPhase 2The University of Texas Health Science Center at San AntonioNCT07470606Written as RaloxifeneHow we know
- New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic HyperplasiaRecruitingPhase 2Beth Israel Deaconess Medical CenterNCT06944145Written as raloxifeneHow we know
- Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian SyndromeCompletedPhase 3Hospital de Clinicas de Porto AlegreNCT00427700Written as raloxifeneHow we know
- Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal WomenCompletedPhase 3Fundació Sant Joan de DéuNCT01573637Written as RaloxifeneHow we know
- Effect of Raloxifene Plus Cholecalciferol and Cholecalciferol Alone on the Bone Mineral Density in Postmenopausal Women With OsteopeniaCompletedPhase 4Yonsei UniversityNCT05386784Written as Raloxifene plus cholecalciferolHow we know
- Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.CompletedPhase 2/3Dompé Farmaceutici S.p.ANCT05172050Written as RaloxifeneHow we know
- Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?CompletedPhase 4The AlfredNCT01481883Written as Raloxifene HydrochlorideHow we know
- Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of DiseaseCompletedNot applicableMemorial Sloan Kettering Cancer CenterNCT00200174Written as Raloxifene followed by combination therapyHow we know
- Comparative Antiresorptive Efficacy Discontinuation of DenosumabActive, not recruitingPhase 4Massachusetts General HospitalNCT03623633Written as raloxifeneHow we know
- Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid ArthritisCompletedNot applicableSara Saeidi ShahriNCT02982083Written as Raloxifene hydrochlorideHow we know
- Raloxifene Augmentation in Patients With a Schizophrenia Spectrum DisorderCompletedPhase 3Iris SommerNCT03043820Written as RaloxifeneHow we know
- Selective Estrogen Receptor Modulators for Women of Child-bearing Age With SchizophreniaCompletedPhase 4The AlfredNCT02354001Written as Raloxifene hydrochlorideHow we know
- Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in WomenCompletedPhase 4Shanghai Mental Health CenterNCT03418831Written as Raloxifene HydrochlorideHow we know
- Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing SurgeryWithdrawnPhase 2Mayo ClinicNCT03147196Written as Raloxifene HydrochlorideHow we know
- Osteoporosis Treatment in Post-menopausal WomenStatus unknownPhase 4Taichung Veterans General HospitalNCT03006003Written as RaloxifeneHow we know
- Nutritional Supplements and Hormonal Manipulations for Breast Cancer PreventionCompletedNot applicableMilton S. Hershey Medical CenterNCT00723398Written as Raloxifene 60 Mg Oral TabletHow we know
- Efficacy Study of Raloxifene to Induce Ovulation in Polycystic Ovarian SyndromeTerminatedNot applicableBruce LesseyNCT01607320Written as RaloxifeneHow we know
- Cognition in the Study of Tamoxifen and RaloxifeneCompletedPhase 3Wake Forest UniversityNCT00687102Written as raloxifeneHow we know
- Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate CancerCompletedEarly Phase 1Mayo ClinicNCT01050842Written as raloxifeneHow we know
- The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by EndometriosisCompletedPhase 2Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NCT00001848Written as RaloxifeneHow we know
See all 47 studies that test raloxifene →
Given beside what is tested · 4 — raloxifene is usual care or a partner of the new treatment
- Evaluating the Pharmacokinetic Characteristics of AD-101 in Healthy VolunteersCompletedPhase 1Addpharma Inc.NCT03764462Written as Raloxifene 60mgHow we know
- Evaluating the Pharmacokinetic Characteristics of AD-102 in Healthy VolunteersCompletedPhase 1Addpharma Inc.NCT03824171Written as Raloxifene 60mg/Cholecalciferol 800IUHow we know
- DP-R213 Phase 1 Pharmacokinetics StudyCompletedPhase 1Alvogen KoreaNCT03010267Written as RaloxifeneHow we know
- DP-R213 Pharmacokinetics StudyCompletedPhase 1Alvogen KoreaNCT02762643Written as RaloxifeneHow we know
As the comparator · 5 — what is tested is compared with raloxifene
- 3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal WomenCompletedPhase 3BayerNCT00310531Written as RaloxifeneHow we know
- Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone LossCompletedPhase 3Ligand PharmaceuticalsNCT00163137Written as raloxifeneHow we know
- Risedronate vs Raloxifene in Hormone Replacement Therapy DiscontinuationTerminatedPhase 4SanofiNCT00790101Written as RaloxifeneHow we know
- Study Comparing Arzoxifene With Raloxifene in Women After Menopause With OsteoporosisCompletedPhase 3Eli Lilly and CompanyNCT00383422Written as RaloxifeneHow we know
- Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal WomenCompletedPhase 3Wyeth is now a wholly owned subsidiary of PfizerNCT00675688Written as RaloxifeneHow we know
Codes
What other systems call raloxifene · ClinicalTrials.gg INT008774
- MeSH (NLM) D020849Raloxifene HydrochlorideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) YX9162EO3IRALOXIFENEConfirmed FDA, NLM, Wikidata
- RxNorm 72143Confirmed FDA, Wikidata
- Wikidata Q425223raloxifeneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1518RaloxifeneOne source FDA
- DrugBank DB00481One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D020849 | Raloxifene Hydrochloride | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | YX9162EO3I | RALOXIFENE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 72143 | — | Confirmed FDA, Wikidata |
| Wikidata | Q425223 | raloxifene | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1518 | Raloxifene | One source FDA |
| DrugBank | DB00481 | — | One source Wikidata |
Also registered as raloxifene hydrochloride (UNII 4F86W47BR6 · RxNorm 166551).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.